Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemiaHagop M. Kantarjian, Jean‐Pierre J. Issa, Guillermo Garcia‐Manero et al.|Blood|2006Cited by 691